136 related articles for article (PubMed ID: 37467950)
1. Leveraging external evidence using Bayesian hierarchical model and propensity score in the presence of covariates.
Chen X; Yao Y; Wang L; Mukhopadhyay S
Contemp Clin Trials; 2023 Sep; 132():107301. PubMed ID: 37467950
[TBL] [Abstract][Full Text] [Related]
2. Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data.
Liu M; Bunn V; Hupf B; Lin J; Lin J
Stat Med; 2021 Sep; 40(22):4794-4808. PubMed ID: 34126656
[TBL] [Abstract][Full Text] [Related]
3. Bayesian adaptive randomization design incorporating propensity score-matched historical controls.
Sawamoto R; Oba K; Matsuyama Y
Pharm Stat; 2022 Sep; 21(5):1074-1089. PubMed ID: 35278032
[TBL] [Abstract][Full Text] [Related]
4. Bayesian Divide-and-Conquer Propensity Score Based Approaches for Leveraging Real World Data in Single Arm Clinical Trials.
Baron E; Zhu J; Tang RS; Chen MH
J Biopharm Stat; 2022 Jan; 32(1):75-89. PubMed ID: 35094643
[TBL] [Abstract][Full Text] [Related]
5. Propensity score-integrated power prior approach for augmenting the control arm of a randomized controlled trial by incorporating multiple external data sources.
Lu N; Wang C; Chen WC; Li H; Song C; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2022 Jan; 32(1):158-169. PubMed ID: 34756158
[TBL] [Abstract][Full Text] [Related]
6. Propensity score-integrated power prior approach for incorporating real-world evidence in single-arm clinical studies.
Wang C; Li H; Chen WC; Lu N; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2019; 29(5):731-748. PubMed ID: 31530111
[TBL] [Abstract][Full Text] [Related]
7. Bayesian Approach for Addressing Differential Covariate Measurement Error in Propensity Score Methods.
Hong H; Rudolph KE; Stuart EA
Psychometrika; 2017 Dec; 82(4):1078-1096. PubMed ID: 27738956
[TBL] [Abstract][Full Text] [Related]
8. Propensity score-integrated Bayesian prior approaches for augmented control designs: a simulation study.
Wang X; Suttner L; Jemielita T; Li X
J Biopharm Stat; 2022 Jan; 32(1):170-190. PubMed ID: 34939894
[TBL] [Abstract][Full Text] [Related]
9. Covariate handling approaches in combination with dynamic borrowing for hybrid control studies.
Fu C; Pang H; Zhou S; Zhu J
Pharm Stat; 2023; 22(4):619-632. PubMed ID: 36882191
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
Hupf B; Bunn V; Lin J; Dong C
Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
[TBL] [Abstract][Full Text] [Related]
12. Incorporating Bayesian methods into the propensity score matching framework: A no-treatment effect safety analysis.
Li L; Donnell ET
Accid Anal Prev; 2020 Sep; 145():105691. PubMed ID: 32711214
[TBL] [Abstract][Full Text] [Related]
13. Outcome-adaptive lasso: Variable selection for causal inference.
Shortreed SM; Ertefaie A
Biometrics; 2017 Dec; 73(4):1111-1122. PubMed ID: 28273693
[TBL] [Abstract][Full Text] [Related]
14. Propensity score-integrated approach to survival analysis: leveraging external evidence in single-arm studies.
Chen WC; Lu N; Wang C; Li H; Song C; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2022 May; 32(3):400-413. PubMed ID: 35675348
[TBL] [Abstract][Full Text] [Related]
15. Utility of propensity score-based Bayesian borrowing of external adult data in pediatric trials: A pragmatic evaluation through a case study in acute lymphoblastic leukemia (ALL).
Majumdar A; Rothwell R; Reaman G; Ahlberg C; Roy P
J Biopharm Stat; 2023 Nov; 33(6):737-751. PubMed ID: 36600441
[TBL] [Abstract][Full Text] [Related]
16. Propensity score matching and stratification using multiparty data without pooling.
Wang J; Marion-Gallois R
Pharm Stat; 2023 Jan; 22(1):4-19. PubMed ID: 35733398
[TBL] [Abstract][Full Text] [Related]
17. Comparing the performance of propensity score methods in healthcare database studies with rare outcomes.
Franklin JM; Eddings W; Austin PC; Stuart EA; Schneeweiss S
Stat Med; 2017 May; 36(12):1946-1963. PubMed ID: 28208229
[TBL] [Abstract][Full Text] [Related]
18. Confounder selection strategies targeting stable treatment effect estimators.
Loh WW; Vansteelandt S
Stat Med; 2021 Feb; 40(3):607-630. PubMed ID: 33150645
[TBL] [Abstract][Full Text] [Related]
19. Leveraging historical data into oncology development programs: Two case studies of phase 2 Bayesian augmented control trial designs.
Smith CL; Thomas Z; Enas N; Thorn K; Lahn M; Benhadji K; Cleverly A
Pharm Stat; 2020 May; 19(3):276-290. PubMed ID: 31903699
[TBL] [Abstract][Full Text] [Related]
20. External control arm analysis: an evaluation of propensity score approaches, G-computation, and doubly debiased machine learning.
Loiseau N; Trichelair P; He M; Andreux M; Zaslavskiy M; Wainrib G; Blum MGB
BMC Med Res Methodol; 2022 Dec; 22(1):335. PubMed ID: 36577946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
